Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy.

Muscle & nerve - 1 Feb 2020

Pegoraro Valentina, Missaglia Sara, Marozzo Roberta, Tavian Daniela, Angelini Corrado

Abstract excerpt

BACKGROUND: Neutral lipid storage disease with myopathy (NLSDM) is a rare lipid metabolism disorder. In this study, we evaluated some circulating miRNAs levels in serum samples and the MRI of three affected siblings. METHODS: Three members of one NLSDM family were identified: two brothers and one sister. Muscles of lower and right upper extremities were studied by MRI. Expression profile of miRNAs, obtained from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lipase
Share to Lipid Metabolism, Inborn Errors
Share to Liver

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MicroRNAs

Share to Muscle, Skeletal

Share to Muscular Diseases

Share to Siblings

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 31729045
DOI: 10.1002/mus.26761
PMCID: PMC7004093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy.PMID 31729045Read ↗

Neutral lipid storage disease with myopathy in China: a large multicentric cohort study.Semantic proximity Read ↗

Neutral lipid storage disease with myopathy: clinicopathological and genetic features of nine Iranian patients.Semantic proximity Read ↗

Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.Semantic proximity Read ↗

Muscle MRI in neutral lipid storage disease with myopathy carrying mutation c.187+1G>A.Semantic proximity Read ↗

The clinical, pathological, and genetic characteristics of lipid storage myopathy in northern China.Semantic proximity Read ↗

Two PNPLA2 heterozygous mutations result in neutral lipid storage disease with myopathy: a case report.Semantic proximity Read ↗

A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles.Semantic proximity Read ↗

Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study.Semantic proximity Read ↗

Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients.Semantic proximity Read ↗

Skeletal Muscle Magnetic Resonance Imaging of the Lower Limbs in Late-onset Lipid Storage Myopathy with Electron Transfer Flavoprotein Dehydrogenase Gene Mutations.Semantic proximity Read ↗

A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.Semantic proximity Read ↗

Neutral lipid storage disease with myopathy and myotonia associated to pathogenic variants on PNPLA2 and CLCN1 genes: case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.